OPPENHEIMER ASSET MANAGEMENT INC. - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$253,899
-22.4%
7,122
+0.4%
0.00%
-20.0%
Q2 2023$327,108
+55.6%
7,091
+35.3%
0.01%
+66.7%
Q1 2023$210,164
-11.6%
5,241
+2.1%
0.00%
-25.0%
Q4 2022$237,812
+15.4%
5,133
+48.3%
0.00%
+33.3%
Q2 2022$206,000
-31.8%
3,462
-16.7%
0.00%
-25.0%
Q1 2022$302,000
-0.7%
4,158
+15.1%
0.00%0.0%
Q4 2021$304,000
-9.0%
3,611
-2.5%
0.00%
-20.0%
Q3 2021$334,000
+59.8%
3,703
+102.0%
0.01%
+66.7%
Q1 2021$209,000
-39.6%
1,833
-26.6%
0.00%
-50.0%
Q4 2020$346,000
+30.6%
2,498
-22.6%
0.01%
+20.0%
Q3 2020$265,000
+165.0%
3,226
+43.5%
0.01%
+150.0%
Q1 2020$100,000
+203.0%
2,248
+189.3%
0.00%
+100.0%
Q4 2019$33,000
+6.5%
777
+8.1%
0.00%0.0%
Q3 2019$31,000
-31.1%
719
+2.6%
0.00%0.0%
Q2 2019$45,000
-39.2%
701
-33.9%
0.00%
-50.0%
Q1 2019$74,000
+34.5%
1,060
-15.7%
0.00%
+100.0%
Q4 2018$55,000
+175.0%
1,257
+229.1%
0.00%0.0%
Q3 2017$20,000
-4.8%
382
+11.0%
0.00%0.0%
Q2 2017$21,000
+31.2%
344
+42.7%
0.00%
Q1 2017$16,0002410.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2023
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders